1. MicroRNA-152 inhibits cell proliferation, migration and invasion by directly targeting MAFB in nasopharyngeal carcinoma
    Yan Li et al, 2017, Molecular Medicine Reports CrossRef
  2. Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study
    null Morini et al, 2019, Cancers CrossRef
  3. miR‑125a is upregulated in cancer stem‑like cells derived from TW01 and is responsible for maintaining stemness by inhibiting p53
    Jianjun Chen et al, 2018, Oncology Letters CrossRef
  4. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers
    Faezeh Tolue Ghasaban et al, 2023, Cancer Cell International CrossRef
  5. MicroRNA-205 promotes the tumorigenesis of nasopharyngeal carcinoma through targeting tumor protein p53-inducible nuclear protein 1
    GUOHUI NIE et al, 2015, Molecular Medicine Reports CrossRef
  6. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance
    Rongrong Liao et al, 2018, Molecular Biology Reports CrossRef
  7. Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
    Pui Yan Siak et al, 2023, Journal of Translational Medicine CrossRef
  8. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
    Yuanbo Kang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
  9. MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
    Z Fan et al, 2016, Oncogenesis CrossRef
  10. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a
    Xigang Hu et al, 2017, Cancer Biology & Therapy CrossRef
  11. Potential of miRNAs in cervical cancer chemoresistance
    Farzaneh Karimi et al, 2021, Gene Reports CrossRef
  12. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
    Bernhard Biersack, 2017, Non-coding RNA Research CrossRef
  13. Riddling Substitution of “hsa” to “has” in the Enigmatic MicroRNA Nomenclature
    Riya Vishwakarma et al, 2024, OMICS: A Journal of Integrative Biology CrossRef
  14. Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing
    Fan Wang et al, 2016, Journal of Experimental & Clinical Cancer Research CrossRef
  15. Regulation of Docetaxel Sensitivity in Prostate Cancer Cells by hsa-miR-125a-3p via Modulation of Metastasis-Associated Protein 1 Signaling
    Jian-zhou Liu et al, 2017, Urology CrossRef